Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats

Amino Acids

Volumn 41, Issue 4, 2011, Pages 901-908

  Nardelli, Tarlliza Romanna ^a   Ribeiro, Rosane Aparecida ^b   Balbo, Sandra Lucinei ^a   Vanzela, Emerielle Cristine ^b   Carneiro, Everardo Magalhães ^b   Boschero, Antonio Carlos ^b   Bonfleur, Maria Lúcia ^a  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

MSG; NEFA; Obesity; Taurine supplementation; TG

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; GLUTAMATE SODIUM; INSULIN; TAURINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID STORAGE; MALE; NEWBORN; NONHUMAN; OBESITY; PANCREAS ISLET; PERIEPIDIDYMAL FAT; PRIORITY JOURNAL; RAT; RETROPERITONEAL FAT; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HYPERINSULINISM; INSULIN; ISLETS OF LANGERHANS; LIPIDS; LIVER; MALE; OBESITY; RATS; RATS, WISTAR; SODIUM GLUTAMATE; TAURINE; TRIGLYCERIDES;

RATTUS;

EID: 83255177062     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0789-7     Document Type: Article

References (40)

1. Anuradha CV, Balakrishnan SD (1999) Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat: an animal model of insulin resistance. Can J Physiol Pharmacol 77:749-754
2. Balbo SL, Mathias PC, Bonfleur ML, Alves HF, Siroti FJ, Monteiro OG, Ribeiro FB, Souza AC (2000) Vagotomy reduces obesity in MSG-treated rats. Res Commun Mol Pathol Pharmacol 108:291-296
3. Balbo SL, Grassiolli S, Ribeiro RA, Bonfleur ML, Gravena C, Brito Mdo N, Andreazzi AE, Mathias PC, Torrezan R (2007) Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat. Endocrine 31:142-148
4. Bernardis LL, Patterson BD (1968) Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. J Endocrinol 40:527-528
5. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
6. Boujendar S, Reusens B, Merezak S, Ahn MT, Arany E, Hill D, Remacle C (2002) Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 45:856-866
7. Carneiro EM, Latorraca MQ, Araujo E, Beltra M, Oliveras MJ, Navarro M, Berna G, Bedoya FJ, Velloso LA, Soria B, Martin F (2009) Taurine supplementation modulates glucose homeostasis and islet function. J Nutr Biochem 20:503-511
8. Chen W, Matuda K, Nishimura N, Yokogoshi H (2004) The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet. Life Sci 74:1889-1898
9. Cherif H, Reusens B, Dahri S, Remacle C, Hoet JJ (1996) Stimulatory effects of taurine on insulin secretion by fetal rat islets cultured in vitro. J Endocrinol 151:501-506
10. Cherif H, Reusens B, Ahn MT, Hoet JJ, Remacle C (1998) Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 159:341-348
11. Choi MJ, Kim JH, Chang KJ (2006) The effect of dietary taurine supplementation on plasma and liver lipid concentrations and free amino acid concentrations in rats fed a high-cholesterol diet. Adv Exp Med Biol 583:235-242
12. Dashti N (1992) The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J Biol Chem 267:7160-7169
13. Dawson R Jr (1983) Acute and long lasting neurochemical effects of monosodium glutamate administration to mice. Neuropharmacology 22:1417-1419
14. Duivenvoorden I, Teusink B, Rensen PC, Romijn JA, Havekes LM, Voshol PJ (2005) Apolipoprotein C3 deficiency results in dietinduced obesity and aggravated insulin resistance in mice. Diabetes 54:664-671
15. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
16. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163
17. Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, D Porte Jr (2001) Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 131:354S-360S
18. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, Brumell JH (2007) Ubiquitinated-protein aggregates form in pancreatic betacells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 56:930-939
19. Kaplan B, Karabay G, Zagyapan RD, Ozer C, Sayan H, Duyar I (2004) Effects of taurine in glucose and taurine administration. Amino Acids 27:327-333
20. Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33:2835-2838
21. Macho L, Fickova M, Jezova Zorad S (2000) Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res 49(Suppl 1):S79-S85.
22. Martins AC, Souza KL, Shio MT, Mathias PC, Lelkes PI, Garcia RM (2004) Adrenal medullary function and expression of catecholamine- synthesizing enzymes in mice with hypothalamic obesity. Life Sci 74:3211-3222
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
24. Maturo J, Kulakowski EC (1988) Taurine binding to the purified insulin receptor. Biochem Pharmacol 37:3755-3760
25. Mizushima S, Nara Y, Sawamura M, Yamori Y (1996) Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 403:615-622
26. Murakami S, Kondo Y, Nagate T (2000) Effects of long-term treatment with taurine in mice fed a high-fat diet: improvement in cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp Med Biol 483:177-186
27. Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N (2002) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355-2366
28. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M (2000) Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54-58
29. Nandhini AT, Thirunavukkarasu V, Anuradha CV (2005) Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 31:337-344
30. Nishimura N, Umeda C, Ona H, Yokogoshi H (2002) The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats. J Nutr Sci Vitaminol (Tokyo) 48:483-490
31. Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719-721
32. Olney JW (1971) Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J Neuropathol Exp Neurol 30:75-90
33. Olofsson SO, Boren J (2005) Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J Intern Med 258:395-410
34. Ribeiro RA, Bonfleur ML, Amaral AG, Vanzela EC, Rocco SA, Boschero AC, Carneiro EM (2009) Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets. Diabetes Metab Res Rev 25:370-379
35. Ribeiro RA, Vanzela EC, Oliveira CA, Bonfleur ML, Boschero AC, Carneiro EM (2010) Taurine supplementation: involvement of cholinergic/phospholipase C and protein kinase A pathways in potentiation of insulin secretion and Ca2+ handling in mouse pancreatic islets. Br J Nutr 104(8):1148-1155
36. Tas S, Sarandol E, Ayvalik SZ, Serdar Z, Dirican M (2007) Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems. Arch Med Res 38:276-283
37. Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, Hosokawa Y, Ezaki O (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147:3276-3284
38. Xiao C, Giacca A, Lewis GF (2008) Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia 51:139-146
39. Yanagita T, Han SY, Hu Y, Nagao K, Kitajima H, Murakami S (2008) Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis 7:38
40. Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26:267-271